ALSO IN THIS MONTH'S ISSUE
Coworking Lab Spaces Help Life Science Startups Succeed
While business incubators are not uncommon, facilities like these provide laboratory equipment and staff to manage safety, training, and other lab operations for entrepreneurs to reduce their initial investment expenses.
A Q&A With A COVID-Era New CEO
David Horn Solomon, Ph.D., took on the role of CEO of Pharnext in April 2020, at the beginning of the pandemic and just after the company had seen it’s Phase 3 trial data rejected by the FDA.
To Achieve Gender Parity in Biotech, Focus on Meaningful Impact
Although progress has been made in strengthening diversity in biotech, we continue to fall short of a truly inclusive industry. At Biogen, we focused on where we could make the most immediate impact on DE&I. Here’s what we learned.
Synergistic COVID Therapy Development
From the outside, it may look as if Biophytis took a sharp turn from its focus on aging to address Covid. But look again.
BEYOND THE PRINTED PAGE
Communicating Authentically During Times Of Crisis4/19/2021
John Fowler, cofounder and CEO of Kezar Life Sciences, shares “A Letter to Kezar Employees,” a best practice example of a leader communicating authentically and transparently during times of crisis (i.e., the killing of George Floyd).
A Lesson Learned The Hard Way4/18/2021
Neil Kumar, cofounder and CEO of BridgeBio, discusses his rationale behind why employees didn’t have titles during the startup phase.
BridgeBio’s Neil Kumar Remembers Those Humble Beginnings4/12/2021
Neil Kumar, cofounder and CEO of BridgeBio, a company today valued at more than $10 billion, shares an embarrassing experience of the startup’s humble beginnings.